XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Oct 1, 2023 | (Q2)Jul 2, 2023 | (Q1)Apr 2, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -27.43%1.16B | -27.43%1.16B | -13.98%1.23B | -5.64%1.95B | -31.11%1.7B | --1.6B | --1.6B | 256.76%1.43B | 473.90%2.07B | --2.46B |
-Cash and cash equivalents | 27.40%1.16B | 27.40%1.16B | 8.19%1.23B | -6.29%1.25B | -55.98%998.08M | --913.16M | --913.16M | 183.65%1.14B | 269.09%1.33B | --2.27B |
-Short-term investments | --0 | --0 | --0 | -4.46%706.07M | 259.52%697.33M | --689.92M | --689.92M | --292.97M | --739.06M | --193.96M |
Receivables | -0.06%632.4M | -0.06%632.4M | -6.58%602.14M | -4.71%597.44M | 0.35%588.97M | --632.81M | --632.81M | 19.17%644.57M | -32.74%626.94M | --586.92M |
-Accounts receivable | -0.06%632.4M | -0.06%632.4M | -6.58%602.14M | -4.71%597.44M | 0.35%588.97M | --632.81M | --632.81M | 19.17%644.57M | -32.74%626.94M | --586.92M |
Inventory | -14.13%367.59M | -14.13%367.59M | -7.14%404.57M | -8.10%401.43M | -3.58%414.03M | --428.06M | --428.06M | 15.19%435.7M | -30.03%436.82M | --429.42M |
Other current assets | -44.76%186.23M | -44.76%186.23M | -47.45%211.92M | -47.09%205.63M | 13.46%360.93M | --337.14M | --337.14M | 190.40%403.28M | 104.02%388.63M | --318.12M |
Total current assets | -21.71%2.35B | -21.71%2.35B | -15.96%2.45B | -10.35%3.16B | -19.40%3.06B | --3B | --3B | -6.52%2.91B | 67.16%3.52B | --3.8B |
Non current assets | ||||||||||
Net PPE | -2.23%649.93M | -2.23%649.93M | 3.31%667.24M | -1.68%646.91M | -0.97%652.69M | --664.74M | --664.74M | 4.09%645.89M | -11.44%657.99M | --659.07M |
-Gross PPE | -42.90%649.93M | -42.90%649.93M | 3.31%667.24M | -1.68%646.91M | -0.97%652.69M | --1.14B | --1.14B | 4.09%645.89M | -11.44%657.99M | --659.07M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | ---473.49M | ---473.49M | ---- | ---- | ---- |
Goodwill and other intangible assets | -4.72%9.1B | -4.72%9.1B | -2.44%9.32B | -4.05%9.32B | -3.85%9.42B | --9.56B | --9.56B | -2.24%9.56B | -11.79%9.72B | --9.8B |
-Goodwill | -1.07%6.46B | -1.07%6.46B | 1.37%6.56B | -0.33%6.5B | -0.03%6.5B | --6.53B | --6.53B | 1.52%6.47B | -10.01%6.52B | --6.51B |
-Other intangible assets | -12.62%2.64B | -12.62%2.64B | -10.44%2.76B | -11.63%2.83B | -11.40%2.92B | --3.02B | --3.02B | -9.29%3.09B | -15.22%3.2B | --3.29B |
Other non current assets | -15.91%288.4M | -15.91%288.4M | 8.21%332.22M | -7.70%296.79M | -22.26%297.64M | --342.97M | --342.97M | -1.69%307.03M | -0.83%321.57M | --382.87M |
Total non current assets | -4.93%10.04B | -4.93%10.04B | -1.78%10.32B | -4.01%10.27B | -4.33%10.37B | --10.56B | --10.56B | -1.86%10.51B | -11.48%10.7B | --10.84B |
Total assets | -8.64%12.39B | -8.64%12.39B | -4.86%12.77B | -5.58%13.42B | -8.23%13.43B | --13.56B | --13.56B | -2.91%13.42B | 0.20%14.22B | --14.64B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -42.70%167.46M | -42.70%167.46M | -6.32%176.41M | -25.81%174.87M | -31.23%183.53M | --292.28M | --292.28M | -31.73%188.3M | -29.36%235.72M | --266.88M |
-accounts payable | -17.96%167.46M | -17.96%167.46M | -6.32%176.41M | -25.81%174.87M | -31.23%183.53M | --204.12M | --204.12M | -31.73%188.3M | -29.36%235.72M | --266.88M |
-Total tax payable | ---- | ---- | ---- | ---- | ---- | --88.16M | --88.16M | ---- | ---- | ---- |
Current accrued expenses | 116.14%485.4M | 116.14%485.4M | -4.04%510.49M | -22.76%503.73M | -41.37%479.25M | --224.57M | --224.57M | 12.82%532M | -7.61%652.17M | --817.43M |
Current debt and capital lease obligation | -99.97%242K | -99.97%242K | -99.86%1.05M | 48.54%711.41M | 48.40%711.44M | --754.78M | --754.78M | 44.48%727.54M | 11,357.80%478.94M | --479.42M |
-Current debt | -99.97%242K | -99.97%242K | -99.86%1.05M | 48.54%711.41M | 48.40%711.44M | --721.87M | --721.87M | 44.48%727.54M | 11,357.80%478.94M | --479.42M |
-Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | --32.91M | --32.91M | ---- | ---- | ---- |
Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | --135.56M | --135.56M | ---- | ---- | ---- |
Current liabilities | -54.97%653.1M | -54.97%653.1M | -52.49%687.94M | 1.70%1.39B | -12.12%1.37B | --1.45B | --1.45B | -2.55%1.45B | 30.95%1.37B | --1.56B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -0.26%3.3B | -0.26%3.3B | 0.84%3.31B | -18.43%3.29B | -18.32%3.29B | --3.31B | --3.31B | -18.68%3.29B | -13.70%4.03B | --4.03B |
-Long term debt | -0.86%3.15B | -0.86%3.15B | 1.05%3.19B | -18.57%3.16B | -18.45%3.16B | --3.18B | --3.18B | -19.13%3.15B | -13.39%3.88B | --3.88B |
-Long term capital lease obligation | 14.13%151.51M | 14.13%151.51M | -4.12%128.4M | -14.60%123.13M | -14.86%127.2M | --132.75M | --132.75M | -6.24%133.92M | -21.21%144.19M | --149.39M |
Other non current liabilities | -17.23%770.52M | -17.23%770.52M | -14.81%846M | -7.87%878.79M | -8.95%919.8M | --930.95M | --930.95M | -19.38%993.05M | -27.27%953.84M | --1.01B |
Total non current liabilities | -3.98%4.07B | -3.98%4.07B | -2.79%4.16B | -16.40%4.16B | -16.44%4.21B | --4.24B | --4.24B | -18.84%4.28B | -16.68%4.98B | --5.04B |
Total liabilities | -16.98%4.73B | -16.98%4.73B | -15.35%4.85B | -12.51%5.55B | -15.42%5.59B | --5.69B | --5.69B | -15.26%5.73B | -9.60%6.35B | --6.6B |
Shareholders'equity | ||||||||||
Share capital | ---- | ---- | -1.02%122.09M | -0.79%123.37M | -1.98%123.49M | --123.43M | --123.43M | -2.27%123.35M | -1.48%124.35M | --125.98M |
-common stock | ---- | ---- | -1.02%122.09M | -0.79%123.37M | -1.98%123.49M | --123.43M | --123.43M | -2.27%123.35M | -1.48%124.35M | --125.98M |
-Preferred stock | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | ---- | ---- | 3.97%5.76B | 2.43%5.67B | 2.09%5.63B | --5.61B | --5.61B | 14.59%5.54B | 16.44%5.54B | --5.51B |
Paid-in capital | ---- | ---- | -5.74%2.27B | -3.84%2.42B | -10.32%2.42B | --2.42B | --2.42B | -12.49%2.41B | -8.43%2.51B | --2.7B |
Gains losses not affecting retained earnings | ---- | ---- | 38.85%-231.92M | -12.12%-341.93M | -6.89%-325.35M | ---276.69M | ---276.69M | 41.64%-379.24M | 33.57%-304.97M | ---304.38M |
Total stockholders'equity | -2.61%7.67B | -2.61%7.67B | 2.96%7.92B | 0.00%7.87B | -2.33%7.85B | --7.87B | --7.87B | 8.90%7.69B | 9.81%7.87B | --8.03B |
Total equity | -2.61%7.67B | -2.61%7.67B | 2.96%7.92B | 0.00%7.87B | -2.33%7.85B | --7.87B | --7.87B | 8.90%7.69B | 9.81%7.87B | --8.03B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |